Status:

ACTIVE_NOT_RECRUITING

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

Lead Sponsor:

Novo Nordisk A/S

Conditions:

Obesity

Eligibility:

All Genders

6-12 years

Phase:

PHASE3

Brief Summary

The study looks at how liraglutide works on participant's body weight. Researchers will look at how liraglutide can help children with obesity to lose weight. They will look at how much weight the chi...

Eligibility Criteria

Inclusion

  • Informed consent of parent(s) or legally acceptable representative of subject and child assent, as age-appropriate, obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial
  • Male or female, aged 6 to below 12 years at the time of signing informed consent
  • Tanner stage 1-5 pubertal development at the time of signing informed consent
  • BMI above or equal to 95th percentile, on gender and age-specific growth charts (CDC.gov)
  • History of failing to lose sufficient weight with lifestyle modification as judged by the investigator
  • For subjects with type 2 diabetes at screening the following inclusion criterion apply in addition:
  • \- Hemoglobin A1c (HbA1c) below or equal to 10.0 percent (86 mmol/mol) as measured by central laboratory at screening

Exclusion

  • A self-reported (or by parent(s)/LAR (legally acceptable representative) where applicable) change in body weight above 5 kg (11 lbs) within 90 days before screening irrespective of medical records
  • Treatment with any medication for the indication of obesity within the past 90 days before screening
  • Type 1 diabetes
  • Subjects with secondary causes of obesity (for example hypothalamic, monogenic or endocrine causes)

Key Trial Info

Start Date :

March 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 15 2027

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT04775082

Start Date

March 4 2021

End Date

January 15 2027

Last Update

December 4 2025

Active Locations (31)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (31 locations)

1

TMC Hlthcr Clin Res Office

Tucson, Arizona, United States, 85712

2

Children's Hospital Colorado

Denver, Colorado, United States, 80045

3

Solaris Clinical Research

Meridian, Idaho, United States, 83646

4

Pennington Biom Res Ctr

Baton Rouge, Louisiana, United States, 70808